As COVID-19 continues to wreak havoc all over the world, many countries are trying to come up with a vaccine against this virus. Now, Australia is beginning its Phase 1 testing to fast-track the release of a vaccine.
Nucleus Network, a clinical trial specialist in Australia is teaming up with Novavax, a biotechnology company in the US and starting to test the NVX-CoV2373 vaccine. It will be the first time that this vaccine will be tested outside the borders of the US.
The CEO of Nucleus mentioned: “Nucleus has a rich history of Phase 1 vaccine trials and a long-standing track-record with Novavax; we are well-positioned to implement rapid testing with first-in-human trials over the coming weeks.”
According to the CEO, the capacity of clinics in Brisbane and Melbourne, it will be possible to fast-track the process. Novavax had also been able to find early effective vaccine development against MERS and SARS, two different strains of coronavirus.
As per Stanley Erck, the CEO of Novavax, “The urgent global race to develop a vaccine against the COVID-19 pandemic drove our rapid identification and selection of an optimal, highly immunogenic vaccine candidate.”
The tests might begin in the middle of May and the results might be coming out by June.